
Validation of treatment induced specific adverse effect as a predictor of treatment benefit: A case study of NCIC CTG BR21
Keywords: درمان های هدفمند; Targeted therapies; Surrogate endpoints; Phase III clinical trials; Time-dependent covariate; Cox regression model